sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
vildagliptin/metformin 1a pharma 50 mg/1000 mg - filmtabletten
1a pharma gmbh - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin 1a pharma 50 mg/850 mg – filmtabletten
1a pharma gmbh - metformin hydrochlorid; vildagliptin -
sitagliptin/metformin sandoz 50 mg/1000 mg – filmtabletten
sandoz gmbh - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -
sitagliptin/metformin sandoz 50 mg/850 mg – filmtabletten
sandoz gmbh - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -
sitagliptin/metformin actavis 50 mg/1000 mg filmtabletten
actavis group ptc ehf. - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -
sitagliptin/metformin actavis 50 mg/850 mg filmtabletten
actavis group ptc ehf. - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -
sitagliptin/metformin ratiopharm 50 mg/1000 mg filmtabletten
ratiopharm arzneimittel vertriebs-gmbh - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -
sitagliptin/metformin grindeks 50/1000 mg filmtabletten
grindeks as - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -